◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Daito Pharmaceutical Co.,Ltd. (4577) Financial History

Name: Daito Pharmaceutical Co.,Ltd. (4577) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-10-02

Daito Pharmaceutical Co.,Ltd. (4577) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Toyama, Japan with about 1,085 employees. Its market capitalization is roughly JPY 37 billion. In the fiscal year ended 2026-05-31, 4577 reported JPY 50.6B in revenue and JPY 3.2B in net income.

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs.

Interactive charts & full statements → Open the 4577 valuation workbench →

4577 Revenue & Earnings History — Annual Income Statement

Income statement	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Total Revenue	JPY 50.6B	JPY 50.6B	JPY 46.9B	JPY 45.1B	—
Gross Profit	JPY 9.9B	JPY 8.6B	JPY 9.8B	JPY 10.3B	—
Operating Income (EBIT)	JPY 3.6B	JPY 2.6B	JPY 3.9B	JPY 5.2B	—
Net Income	JPY 3.2B	JPY 1.9B	JPY 3.3B	JPY 3.6B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4577 Free Cash Flow History

Cash flow	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Dividends Paid	(JPY 1.1B)	(JPY 998M)	(JPY 907M)	(JPY 931M)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4577 Balance Sheet History

Balance sheet	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Total Assets	JPY 73.3B	JPY 78.0B	JPY 77.7B	JPY 70.6B	—
Total Liabilities	JPY 20.4B	JPY 25.9B	JPY 25.4B	JPY 19.6B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4577 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

GUFICBIO · Gufic Biosciences Limited — ₹43 billion
AARTIDRUGS · Aarti Drugs Limited — ₹39 billion
UNICHEMLAB · Unichem Laboratories Limited — ₹39 billion
GALD · Galderma Group AG — CHF 38 billion
SOLARA · Solara Active Pharma Sciences Limited — ₹34 billion
INDSWFTLAB · Ind-Swift Laboratories Limited — ₹34 billion
4595 · Mizuho Medy Co.,Ltd. — JPY 32 billion
9273 · Koa Shoji Holdings Co.,Ltd. — JPY 32 billion

← 4574 All “0-9” companies 4578 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.